Pier Capital, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Pier Capital, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$7,674,000
+53.4%
326,574
+20.8%
1.26%
+48.2%
Q3 2019$5,002,000
+3.3%
270,389
+3.8%
0.85%
+13.1%
Q2 2019$4,843,000
-26.5%
260,490
-3.3%
0.75%
-26.7%
Q1 2019$6,587,000
+0.1%
269,514
+6.3%
1.02%
-21.7%
Q4 2018$6,578,000
-20.7%
253,600
-3.2%
1.30%
+24.8%
Q3 2018$8,291,000261,9701.05%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders